CMKLR2 Gene

Name chemerin chemokine-like receptor 2
Description Enables adipokinetic hormone binding activity and adipokinetic hormone receptor activity. Predicted to be involved in glucose homeostasis and neuropeptide signaling pathway. Located in nucleoplasm and plasma membrane. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have established that the chemerin receptor now known as CMKLR2 (historically linked to GPR1) is a multifunctional G protein‐coupled receptor that binds the adipokine chemerin to regulate a spectrum of biological processes. Structural analyses have revealed that upon binding chemerin or its active C‑terminal peptide, CMKLR2 engages Gi proteins via a “two‑site” binding mechanism in which a short peptide fragment is sufficient for receptor activation, while an extended interaction with full‑length chemerin further stabilizes the complex. This molecular arrangement underlies downstream MAP kinase signaling cascades and contributes to diverse cellular responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its signaling properties, CMKLR2 plays critical roles in metabolic homeostasis and pathophysiological conditions. Its activation has been implicated in vascular tone regulation and vasoconstriction, and alterations in receptor expression are observed in metabolic conditions such as gestational diabetes, where CMKLR2 signaling is linked to impaired carbohydrate and lipid metabolism during pregnancy. Similarly, distinct chemerin isoforms that engage CMKLR2 have been shown to modulate hepatocyte migration, suggesting a potential protective role against tumor metastasis in hepatocellular carcinoma."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional evidence highlights diverse facets of CMKLR2 function in immunological and developmental contexts. The receptor has been linked to anti-viral functions, as synthetic peptides derived from its N‑terminal region can inhibit HIV‑1 infection by interacting with envelope glycoproteins, underscoring the importance of its extracellular determinants. Genomic and epigenetic studies have further identified CMKLR2 (referred to by its gene symbol GPR1) as an imprinted gene in both human and mouse tissues, with variants showing significant associations with neurological disorders such as Alzheimer’s disease. Moreover, comparative analyses reveal species‐specific variations in CMKLR2 coupling to β‑arrestins, which influence receptor internalization and trafficking properties."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "8"}, {"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Atsushi Jinno-Oue, Nobuaki Shimizu, Yasushi Soda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The synthetic peptide derived from the NH2-terminal extracellular region of an orphan G protein-coupled receptor, GPR1, preferentially inhibits infection of X4 HIV-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M500195200"}], "href": "https://doi.org/10.1074/jbc.M500195200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15919664"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15919664"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Aijun Liu, Yezhou Liu, Geng Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of G protein-coupled receptor GPR1 bound to full-length chemerin adipokine reveals a chemokine-like reverse binding mode."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Biol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pbio.3002838"}], "href": "https://doi.org/10.1371/journal.pbio.3002838"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39466725"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39466725"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Amanda J Kennedy, Peiran Yang, Cai Read, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMKLR1), not G-Protein-Coupled Receptor 1 (GPR1), in Human and Rat Vasculature."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Heart Assoc (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/JAHA.116.004421"}], "href": "https://doi.org/10.1161/JAHA.116.004421"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27742615"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27742615"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Binbin Huang, Chen Huang, Huashan Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impact of GPR1 signaling on maternal high-fat feeding and placenta metabolism in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Endocrinol Metab (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpendo.00437.2018"}], "href": "https://doi.org/10.1152/ajpendo.00437.2018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30835511"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30835511"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Susanne Feder, Astrid Bruckmann, Nichole McMullen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chemerin Isoform-Specific Effects on Hepatocyte Migration and Immune Cell Inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms21197205"}], "href": "https://doi.org/10.3390/ijms21197205"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33003572"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33003572"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Hitoshi Hiura, Atsushi Sugawara, Hidehiko Ogawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A tripartite paternally methylated region within the Gpr1-Zdbf2 imprinted domain on mouse chromosome 1 identified by meDIP-on-chip."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkq200"}], "href": "https://doi.org/10.1093/nar/gkq200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20385583"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20385583"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Mamoonah Chaudhry, Xingbin Wang, Mikhil N Bamne, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variation in imprinted genes is associated with risk of late-onset Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Alzheimers Dis (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/JAD-142106"}], "href": "https://doi.org/10.3233/JAD-142106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25391383"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25391383"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Gaetan-Nagim Degroot, Valentin Lepage, Marc Parmentier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Atypical Chemerin Receptor GPR1 Displays Different Modes of Interaction with β-Arrestins in Humans and Mice with Important Consequences on Subcellular Localization and Trafficking."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cells (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/cells11061037"}], "href": "https://doi.org/10.3390/cells11061037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35326488"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35326488"}]}]}]}
NCBI Gene ID 2825
API
Download Associations
Predicted Functions View CMKLR2's ARCHS4 Predicted Functions.
Co-expressed Genes View CMKLR2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View CMKLR2's ARCHS4 Predicted Functions.

Functional Associations

CMKLR2 has 1,692 functional associations with biological entities spanning 6 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 23 datasets.

Click the + buttons to view associations for CMKLR2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of CMKLR2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of CMKLR2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of CMKLR2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing CMKLR2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with CMKLR2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DGIdb Drug Targets 2026 interacting drugs for CMKLR2 protein from the DGIdb Drug Targets 2026 dataset.
GO Biological Process Annotations 2025 biological processes involving CMKLR2 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2025 cellular components containing CMKLR2 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by CMKLR2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of CMKLR2 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of CMKLR2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with CMKLR2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of CMKLR2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of CMKLR2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of CMKLR2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of CMKLR2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of CMKLR2 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of CMKLR2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of CMKLR2 gene from the RummaGEO Gene Perturbation Signatures dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of CMKLR2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of CMKLR2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with CMKLR2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2024 pathways involving CMKLR2 protein from the WikiPathways Pathways 2024 dataset.